BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24987399)

  • 1. Comparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination?
    Martinelli JE; Cecato JF; Bartholomeu D; Montiel JM
    Dement Geriatr Cogn Dis Extra; 2014 May; 4(2):113-21. PubMed ID: 24987399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
    Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
    Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds.
    Aprahamian I; Martinelli JE; Neri AL; Yassuda MS
    Int Psychogeriatr; 2010 Feb; 22(1):64-71. PubMed ID: 19814841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer's disease.
    Kato Y; Narumoto J; Matsuoka T; Okamura A; Koumi H; Kishikawa Y; Terashima S; Fukui K
    Neuropsychiatr Dis Treat; 2013; 9():581-6. PubMed ID: 23662057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.
    Roalf DR; Moberg PJ; Xie SX; Wolk DA; Moelter ST; Arnold SE
    Alzheimers Dement; 2013 Sep; 9(5):529-37. PubMed ID: 23260866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clock Drawing Test--Modified and Integrated Approach (CDT-MIA) as an instrument for detecting mild cognitive impairment in a specialized outpatient setting.
    Heinik J; Shaikewitz D
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):171-80. PubMed ID: 19276409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of Screening Accuracy of Mini-Mental State Examination for Mild Cognitive Impairment and Non-Alzheimer's Disease Dementia by Supplementation of Verbal Fluency Performance.
    Kim JW; Lee DY; Seo EH; Sohn BK; Choe YM; Kim SG; Park SY; Choo IH; Youn JC; Jhoo JH; Kim KW; Woo JI
    Psychiatry Investig; 2014 Jan; 11(1):44-51. PubMed ID: 24605123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
    Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
    J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment for apraxia in mild cognitive impairment and Alzheimer's dise.
    Ward M; Cecato JF; Aprahamian I; Martinelli JE
    Dement Neuropsychol; 2015; 9(1):71-75. PubMed ID: 29213944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the Clock Drawing Test as a Cognitive Screening Instrument for Mild Cognitive Impairment and Mild Dementia: an Evaluation Using Three Scoring Systems.
    Kim S; Jahng S; Yu KH; Lee BC; Kang Y
    Dement Neurocogn Disord; 2018 Sep; 17(3):100-109. PubMed ID: 30906399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
    Nasreddine ZS; Phillips NA; Bédirian V; Charbonneau S; Whitehead V; Collin I; Cummings JL; Chertkow H
    J Am Geriatr Soc; 2005 Apr; 53(4):695-9. PubMed ID: 15817019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of praxis test from Cambridge Cognitive Examination (CAMCOG) for Alzheimer's disease: a cross-sectional study.
    Cecato JF; Melo BAR; Moraes GC; Martinelli JE; Montiel JM
    Sao Paulo Med J; 2018; 136(5):390-397. PubMed ID: 30570090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.